Central Asian University (CAU) recently hosted a highly anticipated guest lecture on “Enterprising Ophthalmology,” featuring ELZA’s CEO and CMO, Nikki and Farhad Hafezi.
Exploring comprehensive keratoconus treatment, from cross-linking to surgery, in the highly respected scientific journal Nature Reviews.
Corneal Physician reports on ELZA’s exploration of slit-lamp CXL as a promising, accessible treatment for infectious keratitis.
Progress in ophthalmology depends not only on innovation, but on the structures that allow innovation to be tested, validated, and translated into clinical care. An
Experts explain how screen time affects the cornea and tear film, why the retina is not harmed, and what helps protect eye health.
Prof. Farhad Hafezi from the ELZA Institute provided an insightful update on the Second Global Consensus on Keratoconus during an interview with EyeTube.
In a recently published case report in American Journal of Ophthalmology Case Reports, our team, in collaboration with Brazilian colleagues, describes an unusual case of a “CTK-like syndrome” following sequential intracorneal ring segment (ICRS) implantation and corneal cross-linking (CXL) in a young patient with progressive keratoconus.
Prof. Hafezi presents Femto-CAIRS and high fluence cross-linking, highlighting its advantages for keratoconus treatment and improving visual outcomes
EuroTimes reviews the evolution of corneal cross-linking, from keratoconus stabilisation to customised and therapeutic CXL approaches.
Recent corneal cross-linking advances extend beyond disease stabilization, introducing individualized and second-generation customized treatment approaches for keratoconus.
